A high proportion of CD68+ PD-L1+ and CD68+ IDO-1+ TAMs is associated with a poor prognosis, while the presence of PD-L1+ tumor cells, total TAMs, PD-L1- TAMs, or IDO-1- TAMs does not affect the prognosis. This evidence concerns the gene CD68 and neoplasm.